Vaduse Dermatologiesp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-11-20
Share capital
90 000,00 PLN
Activity description

Vaduse Dermatologie offers facial dermocosmetics, including regenerative and moisturizing creams and a postbiotic serum that supports the skin microbiome. Its lamellar-base formulas are intended for dry, tight, dull skin and skin with a weakened hydrolipid barrier.

Registered address
ul. Tomasza Zana 43/2.1, 20-601 Lublin, Poland
Website
vaduse.comWebsite active
Email
Email address current
Phone
Social media

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.63kMedianUSD 782.27kAverageUSD 24.03m
Net profit
This companyUSD -18.40kMedianUSD 7.91kAverageUSD 2.59m
Operating costs
This companyUSD 19.79kMedianUSD 723.93kAverageUSD 19.92m
Assets
This companyUSD 27.23kMedianUSD 800.34kAverageUSD 29.11m

Bank accounts

Registered as a VAT taxpayer on 2021-02-05. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Trademarks

Vaduse Dermatologie holds 2 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2021.

MarkProtected until
Vadusé DERMATOLOGIEMar 30, 2032
AlphaDerminMay 3, 2031
-dermin CLINIQUE–

Authorized Representatives

Monika Fill – President of the Management Board

Manner of representation

In the case of a multi-member management board, each member is authorised to represent the company independently; however, when incurring liabilities whose value exceeds PLN 50,000.00 (fifty thousand zlotys), action by two members of the management board or by a member of the management board jointly with a commercial proxy is required.

Ownership

OwnerSharesShare valueStake
33$8,022.6933%
Monika Maria Fill (52)
33$8,022.6933%
Bożena Pierścionek (58)
34$8,265.8034%

Beneficial owners

Person

Competitors

Name
Sanford Biotechsp. z o.o.
IMP & Csp. z o.o.
Celvetsp. z o.o.
Cefeasp. z o.o.
Pillberrysp. z o.o.

Change history

DateEvent
2025-06-24Name change
2020-11-20Entered in the register

FAQ

Last updated: 2026-07-17